Literature DB >> 23258531

The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.

Rui-Si Xu1, Xiao-Dong Wu, Si-Qi Zhang, Chang-Feng Li, Lei Yang, Dan-Dan Li, Bao-Gang Zhang, Ying Zhang, Jing-Peng Jin, Bin Zhang.   

Abstract

miRNAs are a class of endogenous non-coding RNA, which can regulate downstream target genes through binding to the 3'UTR of those genes. Numerous studies have indicated that abnormal expression of miRNAs is implicated in tumor development. Aberrant expression of miR-31 has been found in various cancers, including colorectal cancer. Here, we show that miR-31 is upregulated in human colon cancer tissues and cell lines, and that repression of miR-31 inhibited colon cancer cell proliferation and colony formation in soft agarose. To further elucidate the mechanism underlying the role of miR-31 in promoting colon cancer, we used online miRNA target prediction databases and found that the tumor suppressor RhoTBT1 may be a target of miR-31. Imunohistochemistry assay revealed that RhoBTB1 was significantly decreased in HT29 cells. In addition, ectopic expression of miR-31 reduced RhoBTB1 in the colon cancer cell line HT29. The results suggested that suppression of RhoBTB1 may be responsible for colon tumorigenesis, which was inhibited directly by miR-31. The results of MTT and soft agarose colony-formation assays showed that knockdown of RhoBTB1 by RNAi induced cell proliferation, and colony formation in soft agarose, which mimicked the function of miR-31. This further suggested that suppression of RhoBTB1 was responsible for colon tumorigenesis. In conclusion, we found that miR-31 acts as an oncogene in colon cancer and identified RhoBTB1 as a new target of miR-31 further study demonstrated that miR-31 contributed to the development of colon cancer at least partly by targeting RhoBTB1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23258531     DOI: 10.3892/ijo.2012.1746

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  33 in total

1.  microRNA-31 modulates skeletal patterning in the sea urchin embryo.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Development       Date:  2015-09-23       Impact factor: 6.868

2.  miR-31-5p may enhance the efficacy of chemotherapy with Taxol and cisplatin in TNBC.

Authors:  Xiaowei Shen; Jiaqi Lei; Lei Du
Journal:  Exp Ther Med       Date:  2019-11-12       Impact factor: 2.447

Review 3.  Function and regulation of microRNA-31 in development and disease.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Mol Reprod Dev       Date:  2016-08-02       Impact factor: 2.609

Review 4.  An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.

Authors:  Wenhao Weng; Junlan Feng; Huanlong Qin; Yanlei Ma; Ajay Goel
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

Review 5.  Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.

Authors:  María Antonia Lizarbe; Jorge Calle-Espinosa; Eva Fernández-Lizarbe; Sara Fernández-Lizarbe; Miguel Ángel Robles; Nieves Olmo; Javier Turnay
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

Review 6.  Rho GTPases: Regulation and roles in cancer cell biology.

Authors:  Raquel B Haga; Anne J Ridley
Journal:  Small GTPases       Date:  2016-09-14

7.  Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.

Authors:  S Wang; Q Li; K Wang; Y Dai; J Yang; S Xue; F Han; Q Zhang; J Liu; W Wu
Journal:  Clin Transl Oncol       Date:  2013-02-14       Impact factor: 3.405

Review 8.  An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Ajay Goel
Journal:  Expert Rev Mol Diagn       Date:  2014-08-28       Impact factor: 5.225

9.  Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis.

Authors:  Jun Shen; Jipei Liao; Maria A Guarnera; HongBin Fang; Ling Cai; Sanford A Stass; Feng Jiang
Journal:  J Thorac Oncol       Date:  2014-01       Impact factor: 15.609

10.  MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma.

Authors:  Wei Meng; Zhenqing Ye; Ri Cui; James Perry; Vaia Dedousi-Huebner; Alexander Huebner; Yao Wang; Bin Li; Stefano Volinia; Hiroshi Nakanishi; Taewan Kim; Sung-Suk Suh; Leona W Ayers; Patrick Ross; Carlo M Croce; Arnab Chakravarti; Victor X Jin; Tim Lautenschlaeger
Journal:  Clin Cancer Res       Date:  2013-08-14       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.